Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A randomized, double-blind, parallel-group study of the reduction of signs and symptoms during treatment with tocilizumab versus adalimumab, both in combination with MTX, in patients with moderate to severe active rheumatoid arthritis and an inadequate response to treatment with only one TNF inhibitor https://kusajili.fr:443/Trial/JqO9JqTW9EudNSBWcW0ojw%24a-randomized-double-blind-parallel-group-study-of-the-reduction-of-signs-and-symptoms-during-treatment-with-tocilizumab-versus-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message